The absolute risk of recurrent myocardial infarction is similar amongst both sexes: MONICA Iceland Study 1981–1999

European Journal of Preventive Cardiology

Volumn 11, Issue 2, 2004, Pages 121-124

  Sigurdsson, Gunnar ^a   Sigfusson, Nikulas ^a   Gudmundsdottir, Inga IngibjãƒÂ¶rg ^a   Agnarsson, Uggi ^a   Sigvaldason, Helgi ^b   Gudnason, Vilmundur ^a  

^a ICELANDIC HEART ASSOCIATION   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

gender comparison; myocardial infarction; recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; ICELAND; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; RECURRENT DISEASE; REGISTER; SEX DIFFERENCE; SEX RATIO; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; AGED; FEMALE; HUMANS; ICELAND; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; RISK ASSESSMENT; SEX FACTORS; TIME FACTORS;

EID: 2342649447     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000114973.39211.45     Document Type: Article

References (24)

1. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995; 155: 57–61.
2. National Heart, Lung, and Blood Institute. Morbidity and mortality: 1996 chart-book on cardiovascular, lung, and blood diseases. Bethesda MD: National Institute of Health; 1996.
3. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707–714.
4. Chambless L, Keil U, Dobson A, Mahonen M, Kuulasmaa K, Rajakangas AM, et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985–1990. Multinational MONItoring of Trends and Determinants in Cardiovascular Disease. Circulation 1997; 96: 3849–3859.
5. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988; 41: 105–114.
6. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547–1557.
7. Heckbert SR, Kaplan RC, Weiss NS, Psaty BM, Lin D, Furberg CD, et al. Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy. Arch Intern Med 2001; 161: 1709–1713.
8. Jonsdottir L, Sigfusson N, Gudnason V, Sigvaldason H, Thorgeirsson G. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J Cardiovasc Risk 2002; 9: 67–76.
9. Martin CA, Thompson PL, Armstrong BK, Hobbs MST, de Klerk N. Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register. Circulation 1983; 68: 961–969.
10. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389.
11. Goldberg RJ, Gorak EJ, Yarzebski J, Hosmer DW, Dalen P, Gore JM, et al. A community-wide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation 1993; 87: 1947–1953.
12. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383–390.
13. Tofler GH, Stone PH, Muller JE, Willich SN, Davis VG, Poole WK, et al, and the MILIS Study Group. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women particularly black women. J Am Coll Cardiol 1987; 9: 73–82.
14. Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction. Biology or methodology? JAMA 1990; 263: 1092–1096.
15. Merrilees MA, Scott PJ, Norris RM. Prognosis after myocardial infarction: results of 15 year follow up. BMJ 1984; 288: 356–359.
16. Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation 1996; 93: 1981–1992.
17. Sonke GS, Beaglehole R, Stewart AW, Jackson R, Stewart FM. Sex differences in case fatality before and after admission to hospital after acute cardiac events: analysis of community based coronary heart disease register. BMJ 1996; 313: 853–855.
18. Schreiner PJ, Niemela M, Miettinen H, Mahonen M, Ketonen M, Immonen-Raiha P, et al. Gender differences in recurrent coronary events; the FINMONICA MI register. Eur Heart J 2001; 22: 762–768.
19. Pechacek TF, Asma S, Eriksen MP. Tobacco: global burden and community solutions. In: Yusuf S, Calms A, Camm AJ, Fallen EL, Gersh BJ (editors): Evidence based cardiology. London: BMJ Books; 1998, pp. 165–178.
20. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 1985; 27: 335–371.
21. Anti-thrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of anti-platelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002; 324: 71–86.
22. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605–613.
23. Kristjansson JM, Andersen K. Improved one-year survival after acute myocardial infarction in Iceland between 1986 and 1996. Cardiology 1999; 91: 210–214.
24. Sigfusson N, Sigvaldason H, Steingrimsdottir L, Gudmundsdottir II, Stefansdottir I, Thorsteinsson T, et al. Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ 1991; 302: 1371–1375.